ASD.ai, founded with the mission to revolutionize remote patient monitoring, develops Rootines, a mobile app designed to enhance medication adherence and patient engagement. The app collects self-reported data directly from patients, providing a seamless integration with HUB or Specialty Pharmacy outreach programs. ASD.ai aims to support the pharmaceutical industry by offering a customizable platform that aligns with organizational branding and ensures a consistent patient experience. The app also features patient goal setting to maintain engagement and adherence.
Notable figures affiliated with ASD.ai include its founders and key investors who have a strong background in healthcare technology and pharmaceuticals. The company has achieved significant milestones in improving patient outcomes through enhanced data collection and medication management. ASD.ai's impact is evident in its ability to streamline patient monitoring processes, thus fostering better health management and adherence to treatment plans.
